Intensification of Basal Insulin Therapy with Lixisenatide in Patients with Type 2 Diabetes in a Real-World Setting: The BASAL-LIXI Study

Intensification of Basal Insulin Therapy with Lixisenatide in Patients with Type 2 Diabetes in a Real-World Setting: The BASAL-LIXI Study

ABSTRACT: Background: Basal insulin reduces fasting blood glucose levels, but postprandial blood glucose levels may remain higher. Traditional strategies with rapid insulin intensification can cause hypoglycemic episodes and weight gain. Glucagon-like peptide-1 receptor agonists, such as the short-a...

Full description

Saved in:
Bibliographic Details
Main Authors: Diego Bellido, MD, PhD (Author), Pablo Abellán, MD, PhD (Author), José Manuel Ruiz Palomar, MD (Author), Rogelio Álvarez Sintes, MD (Author), Andreu Nubiolae, MD (Author), Virginia Bellido, MD, PhD (Author), Gracia Romero, PhD (Author)
Format: Book
Published: Elsevier, 2018-01-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items